ArticleBMC musculoskeletal disorders2026
The area and width of the gluteus maximus, gluteus medius/minimus and iliopsoas muscles are associated with the two-year prognosis of patients undergoing hip arthroscopy for femoroacetabular impingement syndrome.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study aims to establish critical thresholds for preoperative muscle area and width that predict two-year postoperative outcomes and to explore the correlation between baseline muscle area and two-year postoperative recovery in patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS). STUDY
designRetrospective Cohort Study, Level IV.
methodsA cohort of 74 patients treated between March 2021 and March 2022 was analyzed. Preoperative MRI measurements were obtained for the cross-sectional area (CSA) and width of the iliopsoas, gluteus maximus, and gluteus medius/minimus muscles. Two years postoperatively, clinical outcomes including the International Hip Outcome Tool-12 (iHOT-12) and the modified Harris Hip Score (mHHS) were assessed. We evaluated correlations between preoperative muscle areas and postoperative outcomes using Pearson correlation coefficients. Multivariate linear regression models were constructed to identify independent associations between muscle CSA/width and postoperative outcomes. Additionally, receiver operating characteristic (ROC) curve analyses were used to explore potential relationships and thresholds between muscle area and the Patient Acceptable Symptom State (PASS) and the Minimal Clinically Important Difference (MCID).
resultsROC analyses demonstrated that pre-G-med/min width and CSA predicted several two-year endpoints, with notable performance for iHOT-12-PASS (width AUC 0.68, P = 0.0070; CSA AUC 0.66, P = 0.020) and mHHS-PASS (width AUC 0.85, P = 0.0030; CSA AUC 0.80, P = 0.0090); gluteus maximus (width AUC 0.67, P = 0.012; CSA AUC 0.67, P = 0.013) and iliopsoas (width AUC 0.69, P = 0.0060; CSA AUC 0.72, P = 0.0010) can predict iHOT-12-PASS. Correlation analyses revealed small-to-moderate positive relationships between preoperative gluteus medius/minimus width and CSA with postoperative mHHS and iHOT-12 scores. In multivariate models, Pre-G-med/min CSA remained a significant positive predictor of 2-year mHHS (β = 0.33, P = 0.034), while male sex emerged as a significant positive predictor for 2-year iHOT-12 (β = 0.35, P = 0.030 in the cross-sectional area model and β = 0.28, P = 0.049 in the width model).
conclusionPreoperative widths and cross-sectional areas of the gluteus medius/minimus, gluteus maximus, and iliopsoas muscles may be associated with, and to a limited extent help predict, the clinical outcomes at two years postoperatively in patients with FAIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.